Effects of Vascular Endothelial Growth Factor Signaling Inhibition on Human Erythropoiesis

Inhibition of vascular endothelial growth factor (VEGF) signaling increases red blood cell (RBC) counts, and erythropoiesis markers have been proposed to guide antiangiogenic therapy in humans. We analyzed RBC measurements in patients enrolled in three studies: a phase II trial of axitinib in thyroi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bhatta, Sumita S., Wroblewski, Kristen E., Agarwal, Kelly L., Sit, Laura, Cohen, Ezra E.W., Seiwert, Tanguy Y., Karrison, Theodore, Bakris, George L., Ratain, Mark J., Vokes, Everett E., Maitland, Michael L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2013
Gaiak:
New Drug Development and Clinical Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3755935/
https://ncbi.nlm.nih.gov/pubmed/23900000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0006
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak